🟢 First Tracks Biotherapeutics is trading 14.4% up in pre-market

First Tracks Biotherapeutics is trading 14.4% higher at $35.00 before the October 8, 2026 open; the cause is unclear.

• Its investor-relations release page lists August 26 as its latest announcement, and searches found no newer company news explaining the move.
• Major indexes were lower in the provided pre-market context, which does not explain the stock’s sharp rise. Available evidence does not establish whether trading reflects company news, sector activity, or another factor.